David H. Deaton
Plus aucun poste en cours
Profil
David H.
Deaton worked as the Chief Medical Officer at Endologix LLC from 2013 to 2016.
Prior to that, he was an Associate Professor at Georgetown University and served as the Chief of the Vascular & Endovascular Surgery Division at Georgetown University Hospital.
Deaton received his undergraduate degree from Haverford College and his doctorate from Duke University School of Medicine.
Anciens postes connus de David H. Deaton
| Sociétés | Poste | Fin |
|---|---|---|
| ENDOLOGIX, INC. | Directeur Technique/Scientifique/R&D | 01/12/2016 |
| Georgetown University | Corporate Officer/Principal | - |
Georgetown University Hospital
 Georgetown University Hospital Medical DistributorsDistribution Services Georgetown University Hospital provides healthcare services. Its services include cancer care, blood cancer, leukemia and myelodysplastic syndromes. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Formation de David H. Deaton
| Haverford College | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Endologix LLC
 Endologix LLC Medical SpecialtiesHealth Technology Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA. | Health Technology |
Georgetown University Hospital
Georgetown University Hospital Medical DistributorsDistribution Services Georgetown University Hospital provides healthcare services. Its services include cancer care, blood cancer, leukemia and myelodysplastic syndromes. The company is headquartered in Washington, DC. | Distribution Services |